Xeno Biosciences Inc.
Biotechnology company · Cambridge, Massachusetts, United States
Xeno Biosciences Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $1.5 million sold in a notice filed in 2023.
Xeno Biosciences at a glance
What does Xeno Biosciences do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $1.5 million sold (2023).
Frequently asked questions about Xeno Biosciences
Where is Xeno Biosciences headquartered?
Xeno Biosciences Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Xeno Biosciences do?
Xeno Biosciences Inc. is a biotechnology company.
When was Xeno Biosciences founded?
The earliest incorporation on record for Xeno Biosciences Inc. is in 2015, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences